a developer of novel gene therapy platform for advancing disease
Industry Biotechnology
A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with ACLX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then ACLX could also see price increases.
Ticker / NAME | Correlation To SLDB | 1D Price Change % | ||
---|---|---|---|---|
SLDB | 100% | -4.50% | ||
ACLX - SLDB | 41% Loosely correlated | -5.05% | ||
KROS - SLDB | 36% Loosely correlated | -4.31% | ||
ABOS - SLDB | 35% Loosely correlated | +3.16% | ||
BBIO - SLDB | 35% Loosely correlated | -2.74% | ||
VCEL - SLDB | 34% Loosely correlated | -4.92% | ||
More |
Ticker / NAME | Correlation To SLDB | 1D Price Change % |
---|---|---|
SLDB | 100% | -4.50% |
drugs theme (254 stocks) | 38% Loosely correlated | -1.67% |
novel medical theme (11 stocks) | 34% Loosely correlated | -1.33% |
biotechnology theme (238 stocks) | 31% Poorly correlated | -1.76% |